Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001493152-24-033195
Filing Date
2024-08-19
Accepted
2024-08-19 18:55:14
Documents
1
Period of Report
2024-08-15

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 11553
  Complete submission text file 0001493152-24-033195.txt   13113
Mailing Address 601 GENOME WAY SUITE 2001 HUNTSVILLE AL 35806
Business Address 601 GENOME WAY SUITE 2001 HUNTSVILLE AL 35806 (256) 327-9630
Serina Therapeutics, Inc. (Issuer) CIK: 0001708599 (see all company filings)

EIN.: 821436829 | State of Incorp.: AL | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O AGEX THERAPEUTICS, INC., 1101 MARINA VILLAGE PARKWAY, SUITE 201 ALAMEDA CA 94501
Business Address
MINTZ STEVEN (Reporting) CIK: 0002008741 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38519 | Film No.: 241222198